"Das Elisabeth-Krankenhaus – Essens erstes Krankenhaus – steht heute für die Bündelung von medizinisch-technischem Know-how und für eine moderne Infrastruktur. Das Krankenhaus verfügt über mehr als 500 Betten. Stationäre und auch ambulante medizinische Behandlungen werden hier auf höchstem Niveau angeboten."

During the past decade, Elisabeth Krankenhaus Essen conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elisabeth Krankenhaus Essen" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Biotronik SE & Co. KG" with 5 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Stiftung Institut fuer Herzinfarktforschung" with 3 trials sponsored and "Direct Flow Medical, Inc." with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elisabeth Krankenhaus Essen" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "BARMER GEK Germany" with 1 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator and "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Elisabeth Krankenhaus Essen" are "Coronary Artery Disease" (9 trials), "Heart Failure" (8 trials), "Aortic Valve Stenosis" (4 trials), "Acute Coronary Syndrome" (3 trials) and "Coronary Disease" (3 trials). Many other conditions were trialed in "Elisabeth Krankenhaus Essen" in a lesser frequency.

Most popular intervention types in "Elisabeth Krankenhaus Essen" are "Device" (35 trials), "Drug" (9 trials), "Procedure" (7 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "WATCHMAN Left Atrial Appendage Closure" (2 trials), "XIENCE" (2 trials), "1 Stent" (1 trials), "2 Stents" (1 trials) and "ABSORB Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elisabeth Krankenhaus Essen" are 49 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Elisabeth Krankenhaus Essen". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Elisabeth Krankenhaus Essen, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Elisabeth Krankenhaus Essen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 21 trials that are defined as “Not Applicable".